Sapienza University of Rome
Roma, Italy
NCT Number: NCT04877925
Objectives: Chest tubes are routinely inserted after thoracic surgery procedures in different size and numbers. The aim of this study is to assess the efficacy of Smart Drain Coaxial drainage compared with two standard chest tubes in patients undergoing thoracotomy for pulmonary lobectomy. 98 patients (57 males and 41 females, mean age 68.3±7.4 years) with lung cancer undergoing open pulmonary lobectomy were randomized in two groups: 50 received one upper 28-Fr and one lower 32-Fr standard chest tube (ST group) and 48 received one 28-Fr Smart Drain Coaxial tube (CT group). Hospitalization data, quantity of fluid output, air leaks, radiograph findings, pain control and costs were assessed.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Roma, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 standard postoperative chest tube used
1 postoperative smart drain coaxial tube
Time frame: 1 postoperative day
Quality of fluid drainage evaluated in mL and by means of a chest X rays
Time frame: 1 postoperative day
Quality of air drainage evaluated by chest X rays
Time frame: within 24 hours after tubes removal
Pneumothorax evaluated by chest x rays
Time frame: 1 postoperative day
evaluation of patient's pain with a 1 - 10 scale ( 0 no pain - 10 maximum pain)
Time frame: until discharge, an average of 6 days
Evaluation of hospital costs in euros during the hospitalization
Time frame: until discharge, an average of 6 days
Duration of hospitalization in days after the operation
Marco Anile
Other
Coaxial Drainage Versus Standard Chest Tube After Pulmonary Lobectomy: a Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00340405
Lung Cancer, Lung Diseases
Beijing, China
View Trial DetailsNCT03117946
Head and Neck Cancer, Head and Neck Neoplasms
Besançon, France
View Trial DetailsNCT05832008
Adherence, Patient, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06084208
Lung Cancer, Lung Diseases
Nijmegen, Netherlands
View Trial Details